In the realm of neonatal care, gastroesophageal reflux (GER) remains a pervasive and challenging condition, particularly in preterm infants whose delicate physiology often complicates traditional diagnostic and therapeutic approaches. A groundbreaking study published in the Journal of Perinatology in 2025 sheds new light on the nuanced differences in reflux characteristics among preterm infants fed on human milk versus those nourished with formula. This research provides pivotal insights into how nutrition influences reflux dynamics and offers practical implications for optimizing clinical outcomes in this vulnerable population.
Preterm infants, born before the completion of 37 weeks of gestation, face a slew of developmental hurdles, one of which is immature gastroesophageal function. The motility and barrier mechanisms protecting the esophagus from acidic stomach contents are underdeveloped, predisposing this group to GER events that can exacerbate respiratory problems and impair growth. Prior studies largely treated preterm infants as a homogeneous cohort when evaluating reflux, often overlooking the profound effects that the type of enteral feeding might exert on reflux episodes.
This comprehensive study meticulously investigates the reflux profiles of preterm infants fed exclusively on human milk compared to those receiving formula, leveraging state-of-the-art multichannel intraluminal impedance-pH (MII-pH) monitoring. Unlike traditional pH monitoring, MII-pH detects both acid and non-acid reflux, offering a detailed portrayal of reflux episodes, including their frequency, duration, and proximal extent. These parameters are vital for understanding the physiologic and pathologic implications of reflux in preterm infants.
Findings from the research reveal that preterm infants fed human milk experience markedly fewer reflux episodes than their formula-fed counterparts. Moreover, the character of the reflux events differs significantly; human milk appears to produce less acidic and shorter duration reflux episodes, which translates to fewer symptomatic episodes and a reduced risk of aspiration-related complications. This observation underscores the protective qualities inherent in human milk, possibly tied to its unique biochemical composition and immunologic factors.
The study delves deeply into the mechanisms that could account for these disparities. Human milk contains bioactive molecules such as epidermal growth factor, secretory immunoglobulin A, and various oligosaccharides which may contribute to enhanced gastroesophageal motility and mucosal defense. Conversely, formulas, often with higher protein and osmolarity, might delay gastric emptying and impair lower esophageal sphincter function, thereby facilitating more frequent and prolonged reflux events.
Clinical implications from these findings are profound. For neonatologists managing preterm infants, recognizing the differential impact of feeding type on GER provides a path to targeted interventions that could reduce morbidity. Encouraging the use of human milk, whether maternal or donor, could not only nurture neurodevelopment but also mitigate reflux-associated complications, potentially decreasing the reliance on pharmacologic agents whose safety profiles remain contentious in this age group.
Further elucidation of reflux microenvironment in these infants also highlights the importance of diagnostic precision. The application of MII-pH monitoring as a diagnostic standard in neonatal units could refine reflux diagnosis by capturing non-acid events often missed by pH monitoring alone. This enhanced detection capability aligns best with the heterogeneous reflux patterns influenced by feed composition, severity of prematurity, and developmental stage, promoting individualized care plans.
The study’s longitudinal data suggest that early-life feeding choices set a trajectory not merely for short-term gastrointestinal health but may influence long-term outcomes such as respiratory morbidity and feeding tolerance. Considering the high rate of rehospitalization and chronic lung disease in this population, insights into optimizing feeding regimens could reduce healthcare burden and improve quality of life for these infants and their families.
Intriguingly, the research also examines the temporal relationship between feeding sessions and the onset of reflux episodes, noting that in formula-fed infants, reflux events were more likely to occur preprandially or well after feeding, while in human milk-fed infants the reflux episodes were sporadic and less correlated with feeding times. This distinction could inform future timing strategies to decrease reflux frequency by modifying feeding intervals or volumes.
From a physiological standpoint, the enhanced digestibility and unique fat composition of human milk may speed gastric emptying and reduce intragastric pressure, both factors that are known to influence reflux propensity. The study underscores the multifaceted nature of reflux pathophysiology in preterm infants, involving an interplay between motility, gastric emptying rates, esophageal clearance, and feed composition.
Equally noteworthy are the broader implications regarding the role of non-nutritive components of human milk in modulating gut microbiota and mucosal immunity. These factors may contribute indirectly to bolstered esophageal integrity and function, further reducing GER’s frequency and severity. While the current research does not delve deeply into the microbiome aspect, it lays the groundwork for future investigations into how microbial colonization patterns modulate GER characteristics.
In the realm of clinical practice, the findings advocate a nuanced approach that combines careful feeding management with the use of objective diagnostic tools. Recognizing the heterogeneity of reflux not just in severity but in nature depending on feed type prompts reconsideration of blanket therapeutic protocols. Instead, personalized medicine approaches become feasible, such as prioritizing human milk feeding, monitoring reflux severity with MII-pH, and tailoring pharmacotherapy only to those infants with significant symptomatic acid reflux.
The study also highlights the limitations of relying solely on clinical symptomatology for diagnosing GER in preterm infants. Symptoms like cough, gagging, or apnea can be nonspecific and overlap with other neonatal conditions. Objective identification of reflux characteristics allows clinicians to distinguish physiological reflux from pathologic forms requiring intervention, preventing unnecessary treatments that may carry side effects.
Technological advancements in impedance monitoring are a milestone for neonatal gastroenterology, empowering researchers and clinicians to map the reflux landscape with unprecedented granularity. This study exemplifies how such technology can generate actionable knowledge that challenges clinical paradigms and advances evidence-based care.
In conclusion, this seminal work delineates distinct differences in reflux patterns of preterm infants depending on feeding modality, emphasizing the superiority of human milk in mitigating reflux burden. These findings urge healthcare providers to champion breast milk feeding initiatives and incorporate advanced diagnostic monitoring to tailor management strategies. Ultimately, this research enriches our understanding of neonatal gastroesophageal physiology and signifies a step forward toward optimizing the health trajectories of the most vulnerable infant populations.
Subject of Research: Gastroesophageal reflux characteristics in preterm-born infants relative to feeding type (human milk versus formula).
Article Title: Distinct gastroesophageal reflux characteristics in preterm-born infants fed human milk versus formula: insights for clinical practice on outcomes.
Article References:
Osborn, E.K., Sultana, Z., Bala, F. et al. Distinct gastroesophageal reflux characteristics in preterm-born infants fed human milk versus formula: insights for clinical practice on outcomes. J Perinatol (2025). https://doi.org/10.1038/s41372-025-02421-y
Image Credits: AI Generated
